Liver disease is the third leading cause of premature death in the UK. Death from chronic liver disease progressively increased in the UK for the past four decades. The rate of death from chronic liver disease in the East Midlands has increased by over 60% in the last 20 years.

The majority of liver disease results from lifestyle-related risk factors including excess alcohol use and obesity / type 2 diabetes and is therefore preventable. Early diagnosis is key to improving crucial to improving survival rates for patients and current conventional 'liver function tests' are insensitive in the detection of chronic liver disease.

EMAHSN’s Scarred Liver Project is implementing a community-based liver pathway focused on risk factors, integrated care across primary and secondary care and novel diagnostic technologies using a non-invasive procedure. (Fibroscan®).
EMAHSN, working in partnership with the NIHR Nottingham Digestive Diseases Biomedication Research Centre BRC, has supported the pathway’s implementation in multiple sites across Nottingham and Leicester.

The evaluation from the first phase of the project is available here.

If you'd like to find out more contact EMAHSN Project Manager This email address is being protected from spambots. You need JavaScript enabled to view it., you can also visit the project's dedicated website.